DiaMedica Therapeutics
(NASDAQ) DMAC
DiaMedica Therapeutics Financials at a Glance
Market Cap
$331.38M
Revenue (TTM)
$0.00
Net Income (TTM)
-$35.10M
EPS (TTM)
-$0.71
P/E Ratio
-8.72
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$6.54
Volume
962,878.473
Open
$6.28
Price
$6.54
Volume
962,878.473
Open
$6.28
Previous Close
$6.55
Daily Range
$6.02 - $6.75
52-Week Range
$3.48 - $10.42
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$6.54
Volume
962,878.473
Open
$6.28
Previous Close
$6.55
Daily Range
$6.02 - $6.75
52-Week Range
$3.48 - $10.42
Estimated Earnings Date
Aug 11, 2026
DMAC News
DMAC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout DiaMedica Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
35
CEO
Rick John Pauls, MBA
Website
www.diamedica.comHeadquarters
Minneapolis, MN 55447, US
DMAC Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-77.09%
Return on Capital
-61.04%
Return on Assets
-66.13%
Earnings Yield
-11.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$331.38M
Shares Outstanding
53.88M
Volume
962.88K
Avg. Volume
178.68K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$36.74M
EBITDA
-$35.03M
Operating Cash Flow
-$31.05M
Capital Expenditure
-$36.19K
Free Cash Flow
-$31.09M
Cash & ST Invst.
$51.33M
Total Debt
$212.00K
DiaMedica Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$331.38M
N/A
Market Cap/Employee
$12.27M
N/A
Employees
27
N/A
Net Income
-$10.04M
-30.3%
EBITDA
-$10.02M
-30.4%
Quarterly Fundamentals
Total Cash
$51.33M
+41.3%
Total Debt
$212.00K
-32.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$97.00K
-54.0%
Short Term Debt
$115.00K
+9.5%
Return on Assets
-66.13%
N/A
Return on Invested Capital
-77.61%
N/A
Free Cash Flow
-$9.09M
-26.9%
Operating Cash Flow
-$9.08M
-27.0%